English | Español
John Breslin | Feb 24, 2016

Partisan-based positions threaten U.S. scientific leadership, ITIF report indicates
Jamie Barrand | Feb 24, 2016

Supplemental New Drug Application submitted to FDA for prostate cancer therapy
Jamie Barrand | Feb 24, 2016

Trial underway for new dosage of HIV-1 therapy
Jamie Barrand | Feb 24, 2016

Romosozumab decreases spinal fracture risk in postmenopausal women, study indicates
Jamie Barrand | Feb 24, 2016

Pricewaterhouse Cooper awards million-dollar grant to Easter Seals Dixon Center
Jamie Barrand | Feb 24, 2016

GSK, Save the Children announce Healthcare Innovation Award winners
Jamie Barrand | Feb 23, 2016

Hotopp receives NIH award for lateral gene transfer research
Jamie Barrand | Feb 23, 2016

European Commission approves marketing for AstraZeneca's new gout treatment

Trending
+ Community
Patient Daily | Apr 17, 2025

ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+ Pharmaceuticals
Patient Daily | Apr 17, 2025

UCSF neurosurgeon: 'The idea that 340B is about helping the poor is a fiction'
+ Pharmaceuticals
Patient Daily | Apr 22, 2025

National Consumers League CEO: 340B program abuse is 'a financial bonanza for non-profit hospitals'
+ Marketing
Patient Daily | Apr 23, 2025

Founder of Medfluence Advisors on SNL copycat skit: 'We’re not mad. We’re flattered'